Specialty · Oncology
Oncology research
Oncology research has its own dense standards stack — RECIST 1.1 for solid-tumour response, iRECIST for immunotherapy, CONSORT extensions for cancer trials, and NCI Common Data Elements for cooperative-group studies. CASRAI vocabulary bridges these field-specific standards to the broader research-administration ecosystem.
Layered onto the general standards
Oncology-specific reporting standards
RECIST 1.1
Response Evaluation Criteria in Solid Tumours; canonical for solid-tumour response assessment.
iRECIST
Modified RECIST for immunotherapy trials — accommodates pseudo-progression and immune-related response patterns.
Cheson criteria (Lugano 2014)
Lymphoma response criteria.
IMWG criteria
Multiple myeloma response.
REMARK
REporting recommendations for tumour MARKer prognostic studies.
NCI CDE
NCI Common Data Elements — standardised data definitions across cooperative groups (NRG, SWOG, ECOG-ACRIN, Alliance, COG).
CONSORT-Outcomes 2022
Extension to CONSORT specifying outcome reporting in any RCT.
CONSORT-AI 2020
Extension for trials involving AI / ML components — relevant for radiomic / digital-pathology trials.
Going deeper
